Detailed answers about PHARMA REGULATORY SERVICES LIMITED, including incorporation, status, business activity, and accounts information.
When was PHARMA REGULATORY SERVICES LIMITED founded?
PHARMA REGULATORY SERVICES LIMITED was officially incorporated on 27 September 2007 and is registered under company number 06384162. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is PHARMA REGULATORY SERVICES LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of PHARMA REGULATORY SERVICES LIMITED?
PHARMA REGULATORY SERVICES LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does PHARMA REGULATORY SERVICES LIMITED do?
PHARMA REGULATORY SERVICES LIMITED operates in the following sectors: 68100 - Buying and selling of own real estate, 68209 - Other letting and operating of own or leased real estate, 74909 - Other professional, scientific and technical activities n.e.c.. These SIC codes provide insight into the company's business activities and industry focus.
What is PHARMA REGULATORY SERVICES LIMITED's registered address?
The registered office address of PHARMA REGULATORY SERVICES LIMITED is 74 THE CHASE, ICKENHAM, MIDDLESEX, UB10 8ST. This is the official address filed with Companies House for legal and statutory correspondence.
Is PHARMA REGULATORY SERVICES LIMITED financially stable?
The most recent accounts for PHARMA REGULATORY SERVICES LIMITED were made up to 31 March 2025, filed as TOTAL EXEMPTION FULL. Next accounts are due by 31 December 2026.